IMPEDANCE TUNER, MAGNETIC RESONANCE SYSTEM, TRANSMISSION APPARATUS, AND TRANSMISSION METHOD

    公开(公告)号:US20230337933A1

    公开(公告)日:2023-10-26

    申请号:US18194862

    申请日:2023-04-03

    IPC分类号: A61B5/055 A61B5/053

    CPC分类号: A61B5/055 A61B5/053

    摘要: An impedance tuner in a magnetic resonance system include at least one of an amplitude tuning circuit and a phase tuning circuit. The amplitude tuning circuit includes M serially-connected amplitude tuners. Each amplitude tuner includes at least one microwave transmission line and a first switch circuit connected in parallel, wherein the first switch circuit controls the at least one microwave transmission line to be in an on state or an off state, respectively, and the value of M is a positive integer greater than or equal to 1. The phase tuning circuit includes a phase tuner, and the phase tuner includes P second microwave transmission lines and a second switch circuit, wherein the second switch circuit controls the P second microwave transmission lines to be in an on state or an off state, respectively, and the value of P is a positive integer greater than or equal to 2.

    Electrical device for monitoring, prevention, and treatment of implant infections

    公开(公告)号:US11751775B2

    公开(公告)日:2023-09-12

    申请号:US16999597

    申请日:2020-08-21

    发明人: David Armbruster

    摘要: A device, having a housing; a power source configured to supply electrical power to a conductive percutaneous implant in a circuit including the conductive percutaneous implant and tissue of a patient adjacent to the conductive percutaneous implant; an electrical sensor configured to generate a signal indicative of at least one electrical parameter of the circuit; and at least one data processing system having one or more processors configured to receive the signal and analyze the signal to determine at least one of a presence or change of infection of the tissue, and pass a control signal to the power source to vary the electrical power responsive to determining at least one of the presence or change of infection of the tissue.

    DIAGNOSIS AND TREATMENT OF PELVIC CONDITIONS
    38.
    发明公开

    公开(公告)号:US20230255512A1

    公开(公告)日:2023-08-17

    申请号:US18133137

    申请日:2023-04-11

    摘要: A system to determine status of a pelvic condition in a subject characterised by abnormal contractility activity of a target pelvic structure is described. The system comprises a sensing module to measure electrical activity of the subject's pelvis at a plurality of time points during the subject's hormonal cycle, a signal processing module configured to receive electrical activity measurements from the sensing module and isolate from the electrical activity measurements electrical contractility parameter measurements representative of the target pelvic structure, and a processor module operably connected to the signal processing module. The processor is configured to receive as an input the electrical contractility parameter measurements representative of the target pelvic structure, generate a data profile of the subject comprising the electrical contractility parameter measurements representative of the target pelvic structure, compare the data profile with a database of reference data profiles comprising reference data profiles of subjects with different pelvic condition status, output the status of the pelvic condition in the subject based on the comparison. In any embodiment, the signal processing module is configured to isolate from the electrical activity measurements slow wave electrical contractility parameter measurements representative of the target pelvic structure. Systems and methods for treating pelvic conditions comprising stimulation of a pelvic structure to normalise pelvic structure contractility are also described.

    Lesion assessment using peak-to-peak impedance amplitude measurement

    公开(公告)号:US11701021B2

    公开(公告)日:2023-07-18

    申请号:US16598400

    申请日:2019-10-10

    申请人: Medtronic, Inc.

    摘要: A method and system for lesion formation assessment in tissue that has undergone an ablation procedure. In one embodiment, a method of assessing lesion formation comprises: recording a baseline impedance measurement from an area of tissue with a medical device; ablating the area of tissue with the medical device; recording a post-treatment impedance measurement from the area of tissue with the medical device; identifying at least one amplitude characteristic of the baseline impedance measurement and identifying at least one amplitude characteristic of the post-treatment impedance measurement; comparing the at least one amplitude characteristic of the baseline impedance measurement and the at least one amplitude characteristic of the post-treatment impedance measurement; generating an indication of efficacy based on the comparison, the indication of efficacy being one of sufficient lesion formation and insufficient lesion formation; and re-ablating the area of tissue if the indication of efficacy is insufficient lesion formation.